Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$0.39 - $0.71 $142,043 - $258,591
-364,214 Reduced 66.11%
186,734 $78,000
Q4 2022

Feb 14, 2023

BUY
$0.33 - $10.44 $49,425 - $1.56 Million
149,773 Added 37.33%
550,948 $220,000
Q3 2022

Nov 14, 2022

BUY
$0.92 - $11.16 $17,645 - $214,048
19,180 Added 5.02%
401,175 $341,000
Q2 2022

Aug 15, 2022

SELL
$1.02 - $1.83 $709,274 - $1.27 Million
-695,367 Reduced 64.54%
381,995 $443,000
Q1 2022

May 16, 2022

SELL
$1.06 - $2.1 $150,391 - $297,945
-141,879 Reduced 11.64%
1,077,362 $1.52 Million
Q4 2021

Feb 14, 2022

SELL
$2.05 - $3.2 $1.4 Million - $2.18 Million
-681,904 Reduced 35.87%
1,219,241 $2.5 Million
Q3 2021

Nov 15, 2021

SELL
$2.54 - $4.07 $946,213 - $1.52 Million
-372,525 Reduced 16.38%
1,901,145 $5.86 Million
Q2 2021

Aug 16, 2021

BUY
$2.57 - $4.85 $286,231 - $540,163
111,374 Added 5.15%
2,273,670 $9.25 Million
Q1 2021

May 17, 2021

BUY
$1.9 - $2.82 $3.09 Million - $4.59 Million
1,625,980 Added 303.18%
2,162,296 $5.34 Million
Q4 2020

Feb 16, 2021

BUY
$1.15 - $2.4 $616,763 - $1.29 Million
536,316 New
536,316 $1.14 Million
Q3 2020

Nov 16, 2020

SELL
$1.11 - $1.68 $39,977 - $60,506
-36,016 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$1.69 - $4.2 $60,867 - $151,267
36,016 New
36,016 $62,000
Q3 2019

Nov 14, 2019

SELL
$1.21 - $1.59 $285,349 - $374,963
-235,826 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$1.25 - $3.14 $601,436 - $1.51 Million
-481,149 Reduced 67.11%
235,826 $356,000
Q1 2019

May 15, 2019

SELL
$2.79 - $4.09 $1.45 Million - $2.12 Million
-518,201 Reduced 41.95%
716,975 $2.12 Million
Q4 2018

Feb 14, 2019

BUY
$3.23 - $7.01 $3.75 Million - $8.13 Million
1,159,874 Added 1540.3%
1,235,176 $4.15 Million
Q3 2018

Nov 14, 2018

BUY
$6.86 - $9.97 $516,571 - $750,760
75,302 New
75,302 $546,000
Q1 2018

May 15, 2018

SELL
$2.92 - $3.81 $764,371 - $997,347
-261,771 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$2.99 - $4.85 $447,734 - $726,258
149,744 Added 133.67%
261,771 $804,000
Q3 2017

Nov 14, 2017

BUY
$3.01 - $5.41 $337,201 - $606,066
112,027
112,027 $527,000

Others Institutions Holding VSTM

About Verastem, Inc.


  • Ticker VSTM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 210,000,000
  • Market Cap $880M
  • Description
  • Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...
More about VSTM
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.